Sherwin Williams grants Davie 7,000 stock options

The options vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions.

Rhea-AI Filing Summary

Sherwin Williams Co. officer Colin M. Davie, Pres. & GM, Glob. Supply Chain, received a grant of 7,000 employee stock options on October 20, 2026, covering 7,000 shares of common stock. The options have a $335.04 exercise price and expire October 19, 2036. They vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions; the reported post-grant option position was 7,000.

Insider Trade Summary

Grant/Award: 7,000 shares

Grant/Award 1 txn

Insider Davie Colin M.

Role Pres. & GM, Glob. Supply Chain

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy) F1	7,000	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (Right to Buy) — 7,000 contracts (Direct)

Footnotes (1)

1. F1. These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

Key Figures

Options granted: 7,000 options Underlying common shares: 7,000 shares Exercise price: $335.04 per share +2 more

5 metrics

Options granted 7,000 options Grant dated October 20, 2026

Underlying common shares 7,000 shares Shares underlying the options

Exercise price $335.04 per share Options granted to Colin M. Davie

Annual vesting installments 3 substantially equal installments Beginning October 20, 2027, subject to vesting conditions

Expiration date October 19, 2036 Employee stock options

Key Terms

Employee Stock Option (Right to Buy), stock option agreement, 2025 Equity and Incentive Compensation Plan, vesting conditions

4 terms

Employee Stock Option (Right to Buy) technical

"Employee Stock Option (Right to Buy)"

stock option agreement technical

"pursuant to the terms of a stock option agreement"

A stock option agreement is a formal contract that gives an individual the right to buy or sell a specific number of shares of a company's stock at a set price within a certain period. For investors, it’s an important tool because it can provide opportunities to profit from stock price movements or to protect against potential losses, making it a key element in financial planning and investment strategies.

2025 Equity and Incentive Compensation Plan technical

"under the 2025 Equity and Incentive Compensation Plan"

vesting conditions technical

"subject to vesting conditions"

Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SHW options did Colin M. Davie receive?

Colin M. Davie received a grant of 7,000 employee stock options on October 20, 2026, covering 7,000 shares of common stock. The exercise price is $335.04 per share.

When do Colin M. Davie's SHW options vest?

The options vest annually in three substantially equal installments beginning October 20, 2027, subject to vesting conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/22/2026 - 04:54 PM EDT Accepted by SEC EDGAR 10/22/2026 - 04:54 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davie Colin M.

(Last) (First) (Middle)

1 SHERWIN WAY

(Street)

CLEVELAND OHIO 44113

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres. & GM, Glob. Supply Chain

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$335.04	10/20/2026		A		7,000		(1)	10/19/2036	Common Stock	7,000	$0	7,000(1)	D

Explanation of Responses:

1. These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	10/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)